… toward the clinic. Instead of targeting the dopamine system, his approach focuses on the glutamate system, which could match the benefit of levodopa without … idea of using mGluR4 for treatment of PD to a point where multiple pharmaceutical companies are now interested in …

… in rats, however, this decrease was not maintained after multiple doses. In contrast, α-syn protein levels remained unchanged in both single and multiple dosing paradigms. Furthermore, clenbuterol did not …

… of Alzheimer’s disease, Huntington’s disease, stroke, multiple sclerosis, Rett syndrome, Down’s syndrome, … small molecule ligands as disease-modifying strategies for multiple neurodegenerative disorders. …

… and more recently at Neumora, He has successfully delivered multiple molecules to ‘Development candidate status’ and … with the Neumora team named on this MJFF proposal on multiple programs including the identification of selective …

… model. The second study will examine the effects of multiple intranasal doses of GDNF given before, at the same … of Parkinson’s Disease: GDNF cannot enter the brain after systemic administration, and the surgery to inject it …

… damaged in Parkinson’s disease have new evidence that these systems become abnormal a few years before symptoms appear. … with a unique opportunity to study the brain scans at multiple times and compare the symptoms to changes in the …